Development of high sustained anti-drug antibody titers and corresponding clinical decline in a late-onset Pompe disease patient after 11+ years on enzyme replacement therapy.
Mol Genet Metab Rep
; 36: 100981, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-37342670
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Mol Genet Metab Rep
Year:
2023
Type:
Article
Affiliation country:
United States